Report Scope
This report provides an in-depth analysis of the global market for liquid biopsy tools, services and diagnostics, including market estimations and trends, using 2023 as the base year and forecasting 2024 through 2029 with a compound annual growth rate (CAGR) projection. The report includes an overview of the industry structure and its competitive landscape. Leading market players’ profiles, product offerings, financial information and recent market activities are provided. The report also assesses companies’ business strategies and their effect in the face of the competitive environment. It details the global market based on application, purpose of analysis, biomarker type and platform. Regional analysis includes North America (U.S., Canada, Mexico), Europe (U.K., Germany, France, Spain, Italy, Rest of Europe), Asia-Pacific (China, India, Japan, and Rest of Asia-Pacific), and the Rest of the world (South America, and the Middle East and Africa).

Report Includes

  • 65 data tables and 58 additional tables
  • Analyses of the trends in the global market for liquid biopsy research tools, services and diagnostics, with market revenue data (sales figures) for 2022, estimates for 2023, forecasts for 2024, and projected CAGRs through 2029
  • Estimates of the market size and revenue growth prospects, along with a market share analysis by application, purpose of analysis, biomarker type, analysis platform (technology type) and region
  • Examination of conventional biopsy methods and liquid biopsy enabling technologies
  • Discussion of large-scale research initiatives
  • Facts and figures pertaining to key market dynamics, technology advances, regulations, and the impact of macroeconomic factors
  • Insights derived from the Porter’s Five Forces model, as well as global supply chain and PESTLE analyses
  • Overview of sustainability trends and ESG developments, with emphasis on consumer attitudes, and the ESG scores and practices of leading companies
  • Patent analysis, including key granted and published patents
  • Analysis of the industry structure, including companies’ market shares and rankings, strategic alliances, M&A activity and a venture funding outlook
  • Profiles of leading companies, including Exact Sciences Corp., Natera Inc., Guardant Health, Roche, and NeoGenomics Laboratories